Elacestrant
2
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 2 mentions across 2 episodes found for "Elacestrant".
Oct 13, 2026
Thomas BlomHOST
Right.
Richard LeeGUEST
Um, so, you know, these ESR1 targeting agents, as you mentioned, and then we've got a bunch of them, but, you know, Orserdu, um, or, um, Elacestrant was one of them, probably one of the first.
Richard LeeGUEST
Uh, Imlunestrant, uh, is another.
Richard LeeGUEST
We have a recent one, Ramacestrant, which I have not yet had the chance to use, which we, we should talk about because that indication is, is sort of an interesting development.
Sydney UrschHOST
It's a pure ER antagonist with no agonist properties, unlike tamoxifen, and is dosed intramuscularly monthly.
Sydney UrschHOST
Elacestrant and imlunestrant are newer oral agents.
Sydney UrschHOST
They may be more effective with certain molecular profiles, especially in ESR1 mutation, which we'll talk more about in our next episode.
Sydney UrschHOST
Maya, want to take the last class, the GnRH agonists?